Suppr超能文献

轴向骨骼中脊索瘤和巨细胞瘤鉴别诊断的形态学及动态对比增强磁共振成像特征

Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.

作者信息

Lang Ning, Su Min-Ying, Xing Xiaoying, Yu Hon J, Yuan Huishu

机构信息

Department of Radiology, Peking University Third Hospital, Beijing, China.

Tu & Yuen Center for Functional Onco-Imaging, Department of Radiological Sciences, University of California, Irvine, California, USA.

出版信息

J Magn Reson Imaging. 2017 Apr;45(4):1068-1075. doi: 10.1002/jmri.25414. Epub 2016 Aug 4.

Abstract

PURPOSE

To characterize the morphological and dynamic-contrast-enhanced (DCE) MRI features of chordoma and giant cell tumor (GCT) of bone occurring in the axial skeleton.

MATERIALS AND METHODS

A total of 13 patients with chordoma and 26 patients with GCT who received conventional T1, T2, and DCE-MRI on 3 Tesla MR scanners were retrospectively identified and analyzed. Two radiologists evaluated morphological features independently, including the lesion location, expansile bone changes, vertebral compression, presence of paraspinal soft tissue mass, fibrous septa, and the signal intensity on T1WI and T2WI. The inter-observer agreement was evaluated by kappa test. The DCE kinetics was measured to obtain the initial area under curve (IAUC) and the wash-out slope; also the two-compartmental pharmacokinetic model was applied to obtain K and k . The diagnostic accuracy was evaluated by CHAID decision tree and ROC analysis.

RESULTS

Chordomas were more likely to show soft tissue mass than GCTs (13/13 = 100% versus 15/26 = 58%; P = 0.007), as well as fibrous septa (9/13 = 69% versus 0; P < 0.001). In decision tree analysis, presence of fibrous septa and lesion location yield 31/39 = 79% accuracy. The DCE-MRI pharmacokinetic parameters K and k of GCTs were significantly higher than those of chordomas, 0.13 ± 0.65 versus 0.06 ± 0.04 (1/min) for K , 0.62 ± 0.22 versus 0.17 ± 0.12 (1/min) for k , P < 0.001 for both. If using kep = 0.43/min as the cut-off value, it achieved 100% sensitivity and 92% specificity to differentiate chordoma from GCT, with an overall accuracy of 37/39 = 95%. The IAUC was highly correlated with K (r = 0.94), and the slope was highly correlated with k (r = 0.95).

CONCLUSION

Several morphological features were significantly different between chordoma and GCT, but their diagnostic performance was inferior to that of DCE-MRI.

LEVEL OF EVIDENCE

4 J. Magn. Reson. Imaging 2017;45:1068-1075.

摘要

目的

描述发生于中轴骨骼的脊索瘤和骨巨细胞瘤(GCT)的形态学及动态对比增强(DCE)MRI特征。

材料与方法

回顾性纳入并分析了13例接受3T MR扫描仪常规T1、T2及DCE-MRI检查的脊索瘤患者和26例GCT患者。两名放射科医生独立评估形态学特征,包括病变位置、骨质膨胀性改变、椎体压缩、椎旁软组织肿块、纤维分隔的存在情况以及T1WI和T2WI上的信号强度。通过kappa检验评估观察者间的一致性。测量DCE动力学以获得初始曲线下面积(IAUC)和廓清斜率;同时应用双室药代动力学模型获得K和k。通过CHAID决策树和ROC分析评估诊断准确性。

结果

脊索瘤比GCT更易出现软组织肿块(13/13 = 100% 对比15/26 = 58%;P = 0.007)以及纤维分隔(9/13 = 69% 对比0;P < 0.001)。在决策树分析中,纤维分隔的存在情况和病变位置的诊断准确率为31/39 = 79%。GCT的DCE-MRI药代动力学参数K和k显著高于脊索瘤,K值为0.13 ± 0.65对比0.06 ± 0.04(1/min),k值为0.62 ± 0.22对比0.17 ± 0.12(1/min),两者P均< 0.001。以kep = 0.43/min作为截断值,鉴别脊索瘤与GCT的敏感性为100%,特异性为92%,总体准确率为37/39 = 95%。IAUC与K高度相关(r = 0.94),斜率与k高度相关(r = 0.95)。

结论

脊索瘤和GCT之间的几种形态学特征存在显著差异,但其诊断性能不如DCE-MRI。

证据水平

4 J.Magn.Reson.Imaging 2017;45:1068 - 1075。

相似文献

2
Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.
Acad Radiol. 2017 Jul;24(7):867-875. doi: 10.1016/j.acra.2016.12.014. Epub 2017 Feb 2.
7
Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
J Magn Reson Imaging. 2018 Apr;47(4):1099-1111. doi: 10.1002/jmri.25835. Epub 2017 Aug 28.
10
DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
J Magn Reson Imaging. 2017 Sep;46(3):837-849. doi: 10.1002/jmri.25631. Epub 2017 Jan 16.

引用本文的文献

1
F-FDG PET/CT revealed primary malignant giant cell tumor of the sacrum: a case report.
Front Med (Lausanne). 2025 Aug 15;12:1653522. doi: 10.3389/fmed.2025.1653522. eCollection 2025.
2
Combining morphological and functional imaging parameters to diagnose primary bone neoplasms in the skull base, spine and sacrum.
Skeletal Radiol. 2025 Feb;54(2):287-302. doi: 10.1007/s00256-024-04742-z. Epub 2024 Jul 5.
3
Low-dose GBCA administration for brain tumour dynamic contrast enhanced MRI: a feasibility study.
Sci Rep. 2024 Feb 28;14(1):4905. doi: 10.1038/s41598-024-53871-x.
5
Current progress and future trends in imaging of musculoskeletal bone tumours.
J Clin Orthop Trauma. 2021 Oct 7;23:101622. doi: 10.1016/j.jcot.2021.101622. eCollection 2021 Dec.
7
Diagnosis of spinal lesions using perfusion parameters measured by DCE-MRI and metabolism parameters measured by PET/CT.
Eur Spine J. 2020 May;29(5):1061-1070. doi: 10.1007/s00586-019-06213-9. Epub 2019 Nov 21.
8
Differentiation of spinal metastases originated from lung and other cancers using radiomics and deep learning based on DCE-MRI.
Magn Reson Imaging. 2019 Dec;64:4-12. doi: 10.1016/j.mri.2019.02.013. Epub 2019 Feb 28.
9
Prognostic Implications of Gadolinium Enhancement of Skull Base Chordomas.
AJNR Am J Neuroradiol. 2018 Aug;39(8):1509-1514. doi: 10.3174/ajnr.A5714. Epub 2018 Jun 14.
10
State-of-the-Art Imaging in Human Chordoma of the Skull Base.
Curr Radiol Rep. 2018;6(5):16. doi: 10.1007/s40134-018-0275-7. Epub 2018 Apr 3.

本文引用的文献

1
Imaging appearance of giant cell tumour of the spine above the sacrum.
Br J Radiol. 2015 Jul;88(1051):20140566. doi: 10.1259/bjr.20140566. Epub 2015 Apr 29.
2
Differentiation of tuberculosis and metastatic cancer in the spine using dynamic contrast-enhanced MRI.
Eur Spine J. 2015 Aug;24(8):1729-37. doi: 10.1007/s00586-015-3851-z. Epub 2015 Mar 8.
4
Magnetic resonance imaging aspects of giant-cell tumours of bone.
J Med Imaging Radiat Oncol. 2014 Dec;58(6):674-8. doi: 10.1111/1754-9485.12249. Epub 2014 Sep 25.
5
Giant cell tumours of the mobile spine: characteristic imaging features and differential diagnosis.
Radiol Med. 2014 Sep;119(9):681-93. doi: 10.1007/s11547-013-0352-1. Epub 2014 Feb 15.
6
Differentiation of primary chordoma, giant cell tumor and schwannoma of the sacrum by CT and MRI.
Eur J Radiol. 2013 Dec;82(12):2309-15. doi: 10.1016/j.ejrad.2013.08.034. Epub 2013 Aug 30.
7
Giant cell tumor of bone: review, mimics, and new developments in treatment.
Radiographics. 2013 Jan-Feb;33(1):197-211. doi: 10.1148/rg.331125089.
8
Differentiation of myeloma and metastatic cancer in the spine using dynamic contrast-enhanced MRI.
Magn Reson Imaging. 2013 Oct;31(8):1285-91. doi: 10.1016/j.mri.2012.10.006. Epub 2013 Jan 3.
9
Imaging of sacral tumours.
Skeletal Radiol. 2008 Apr;37(4):277-89. doi: 10.1007/s00256-007-0413-4. Epub 2007 Nov 23.
10
Giant cell tumor of the lumbar spine: operative management via spondylectomy and short-segment, 3-column reconstruction with pedicle recreation.
Surg Neurol. 2008 Feb;69(2):138-41; discussion 141-2. doi: 10.1016/j.surneu.2007.01.038. Epub 2007 Jun 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验